---
title: "Kepler Capital  Reaffirms Their Hold Rating on INDUS Holding (0EUH)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280553379.md"
description: "Kepler Capital has reaffirmed a Hold rating on INDUS Holding (0EUH) with a price target of €28.00, while the shares closed at €28.45. Analyst Sven Sauer, with a 0.0% average return and 37.22% success rate, indicates a Moderate Buy consensus for INDUS Holding, with an average price target of €33.50."
datetime: "2026-03-26T01:50:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280553379.md)
  - [en](https://longbridge.com/en/news/280553379.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280553379.md)
generator: "portal-rs"
---

# Kepler Capital  Reaffirms Their Hold Rating on INDUS Holding (0EUH)

In a report released on March 24, Sven Sauer from Kepler Capital maintained a Hold rating on INDUS Holding, with a price target of €28.00. The company’s shares closed last Tuesday at €28.45.

### Claim 30% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

According to TipRanks, Sauer is a 2-star analyst with an average return of 0.0% and a 37.22% success rate.

Currently, the analyst consensus on INDUS Holding is a Moderate Buy with an average price target of €33.50.

### Related Stocks

- [INH.DE](https://longbridge.com/en/quote/INH.DE.md)

## Related News & Research

- [Kepler Capital  Sticks to Its Hold Rating for INDUS Holding (0EUH)](https://longbridge.com/en/news/283239857.md)
- [INDUS Holding (0EUH) Receives a Hold from Kepler Capital](https://longbridge.com/en/news/286345482.md)
- [ICG early proxy votes signal shareholder opposition to €8 cash offer ahead of Aug. 28 meeting](https://longbridge.com/en/news/296441164.md)
- [Upcoming Stock Splits This Week (August 24 to August 28) – Stay Invested](https://longbridge.com/en/news/296708264.md)
- [05:28 ETChina's Personalized mRNA Cancer Therapy Sector Accelerates: How Far Is It From a "DeepSeek Moment"?](https://longbridge.com/en/news/296596921.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**